InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Conway Charles, Directeur Scientifique. Director active across 1 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 4 reports have been logged. The latest transaction was disclosed on 6 January 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
03,750 shares0
Common Shares
SEC:0001562180-22-000355·
03,750 shares0
Common Shares
SEC:0001562180-22-000355:0·
€333,92210,000 shares@ €33.39220.025% mcap100.0% of flow
Common Shares
SEC:0001562180-21-007297·
€333,92210,000 shares@ €33.39220.025% mcap50.0% of flow
Common Shares
SEC:0001562180-21-007297:0·
4 of 4 declarations
About Conway Charles
Charles Conway is the Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd. In this role, he oversees the company's research and development initiatives, contributing to innovation and scientific advancement. His expertise is essential for Biohaven.
